Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CMI vs GSK✓SelectedUSD · GSKCMI vs GSK performance historyLatest closeAs of-1.57%11/18
Stock and ETF performance explorer

CMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+108.7%
GSK return
+42.7%
Excess return
+66.0%
Maximum drawdown
-41.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-1.3%-0.2%-1.4%
7D-7.8%-3.1%-4.7%-7.3%
30D-18.2%-0.9%-17.3%-18.1%
3M-30.9%-4.2%-26.8%-30.6%
6M-36.6%-1.6%-35.0%-36.7%
YTD-15.5%+2.6%-18.1%-16.6%
1Y-6.8%+6.2%-13.0%-8.7%
3Y+101.3%+55.0%+46.3%+78.5%
5Y+108.7%+42.8%+65.9%+76.1%
All+108.7%+42.7%+66.0%+76.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling